Biodexa Pharmaceuticals Plc (BDRX)
NASDAQ: BDRX · Real-Time Price · USD
0.8740
-0.0155 (-1.74%)
At close: Jul 11, 2025, 4:00 PM
0.8792
+0.0052 (0.59%)
After-hours: Jul 11, 2025, 4:59 PM EDT
Biodexa Pharmaceuticals Employees
Biodexa Pharmaceuticals had 13 employees as of December 31, 2024. The number of employees decreased by 8 or -38.10% compared to the previous year.
Employees
13
Change (1Y)
-8
Growth (1Y)
-38.10%
Revenue / Employee
n/a
Profits / Employee
-$551,714
Market Cap
2.53M
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
| AbbVie | 55,000 |
BDRX News
- 14 days ago - Results of Annual General Meeting - GlobeNewsWire
- 16 days ago - Biodexa Announces Activation of First Clinical Study Site for Phase 3 Serenta Trial in Familial Adenomatous Polyposis (FAP) - GlobeNewsWire
- 18 days ago - Biodexa Unveils "Serenta" as the Name of its Upcoming Phase 3 Study In Familial Adenomatous Polyposis (FAP) - GlobeNewsWire
- 23 days ago - Biodexa Hits Key Milestone For Its Type 1 Diabetes Candidate Tolimidone, Enrolls First Patient In Phase 2a Study - Accesswire
- 4 weeks ago - Result of General Meeting - GlobeNewsWire
- 5 weeks ago - Biodexa Announces Recruitment of First Patient in Phase 2 Study of Tolimidone in Type 1 Diabetes - GlobeNewsWire
- 6 weeks ago - Shareholder Update - GlobeNewsWire
- 7 weeks ago - Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company”) Notice of General Meeting - GlobeNewsWire